Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma
Conclusion
Patients with low basal albumin-bilirubin grade and neutrophil-lymphocyte ratio survive longer after transarterial radioembolization for unresectable hepatocellular carcinoma. Presence of extrahepatic metastases and portal venous thrombosis seems to have a prognostic value.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Bilirubin | Cancer & Oncology | Carcinoma | Children | Hepatocellular Carcinoma | Liver Cancer | Nuclear Medicine | Study | Thrombosis